oxidopamine and h 89
oxidopamine has been researched along with h 89 in 3 studies
Research
Studies (3)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Hoizey, G; Millart, H; Robinet, A | 1 |
| Canlon, B; Niu, X | 1 |
| Chang, SW; Chen, JH; Chou, RH; Fu, RH; Lin, CY; Tsai, CW; Wu, CR | 1 |
Other Studies
3 other study(ies) available for oxidopamine and h 89
| Article | Year |
|---|---|
PI 3-kinase, protein kinase C, and protein kinase A are involved in the trigger phase of beta1-adrenergic preconditioning.
Topics: Adrenergic beta-Agonists; Androstadienes; Animals; Blotting, Western; Chromones; Coronary Circulation; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Heart Rate; Ischemic Preconditioning, Myocardial; Isoquinolines; Male; Morpholines; Myocardial Reperfusion Injury; Myocardium; Oxidopamine; Perfusion; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase C; Rats; Rats, Wistar; Sulfonamides; Wortmannin; Xamoterol | 2005 |
The signal transduction pathway for the dopamine D1 receptor in the guinea-pig cochlea.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Action Potentials; Animals; Blotting, Western; Cochlea; Cochlear Nerve; Cyclic AMP-Dependent Protein Kinases; Dopamine Agonists; Dopamine and cAMP-Regulated Phosphoprotein 32; Female; Guinea Pigs; Immunohistochemistry; Isoquinolines; Male; Oxidopamine; Perfusion; Receptors, AMPA; Receptors, Dopamine D1; Signal Transduction; Sulfonamides; Sympathectomy, Chemical; Sympatholytics | 2006 |
Inhibition of JNK by pi class of glutathione S-transferase through PKA/CREB pathway is associated with carnosic acid protection against 6-hydroxydopamine-induced apoptosis.
Topics: Abietanes; Apoptosis; Cell Line; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Enzyme Inhibitors; Glutathione S-Transferase pi; Humans; Isoquinolines; MAP Kinase Kinase 4; Neuroprotective Agents; Oxidopamine; Phosphorylation; RNA, Small Interfering; Signal Transduction; Sulfonamides | 2017 |